Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Neuronax S.A.S
DescriptionSynthetic peptide derived from subcommissural organ-spondin
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationSpinal cord injury (SCI)
Indication DetailsTreat spinal cord injuries
Regulatory Designation EU - Orphan Drug (Treat spinal cord injuries)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today